These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 1476793

  • 1. Parenchymal organ cystine depletion with long-term cysteamine therapy.
    Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC.
    Biochem Med Metab Biol; 1992 Dec; 48(3):275-85. PubMed ID: 1476793
    [Abstract] [Full Text] [Related]

  • 2. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G, Williams C, Bernardini I, Gahl WA.
    Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
    Kaufeld J, Weber LT, Kurschat C, Canaan-Kuehl S, Brand E, Oh J, Pape L.
    Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cystine depletion of cystinotic tissues by phosphocysteamine (WR638).
    Thoene JG, Lemons R.
    J Pediatr; 1980 Jun; 96(6):1043-4. PubMed ID: 7373465
    [No Abstract] [Full Text] [Related]

  • 11. [Cystinosis--an orphan disease. Pathogenesis and current treatment].
    Zachwieja J.
    Przegl Lek; 2006 Jun; 63 Suppl 3():29-31. PubMed ID: 16898482
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom.
    Lashilola S, Xu W, Azimpour K, McCarthy M, Carlot S, Game D, van der Voort J.
    BMC Nephrol; 2023 Nov 29; 24(1):351. PubMed ID: 38031005
    [Abstract] [Full Text] [Related]

  • 14. Suppository formulations as a potential treatment for nephropathic cystinosis.
    Buchan B, Kay G, Matthews KH, Cairns D.
    J Pharm Sci; 2012 Oct 29; 101(10):3729-38. PubMed ID: 22778070
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nephropathic cystinosis in children: An overlooked disease.
    Soliman NA, El-Baroudy R, Rizk A, Bazaraa H, Younan A.
    Saudi J Kidney Dis Transpl; 2009 May 29; 20(3):436-42. PubMed ID: 19414947
    [Abstract] [Full Text] [Related]

  • 19. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.
    Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA.
    Medicine (Baltimore); 2005 May 29; 84(3):137-146. PubMed ID: 15879904
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.